Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

FluoGuide

41,9

 

SEK

 

-2,78 %

Mindre end 1K følgere

FLUO

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Sammenligne
-2,78%
+5,81%
-4,34%
+7,02%
+13,55%
-14,92%
-18,64%
+10,89%
+367,36%

FluoGuide er en dansk virksomhed, der er aktiv inden for medicinsk teknologi. Virksomhedens forretningsfokus findes i forskning og udvikling af behandlinger mod forskellige former for kræft, med størst fokus på udvikling af produkter, der styrer kirurgiske indgreb. Produkterne binder sig til kræftcellerne, som så lyser op og er beregnet til at blive brugt til præcist at fjerne skadelige svulster i patientens væv.

Læs mere
Markedsværdi
570,68 mio. SEK
Aktieomsætning
310,62 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
28.8
2025

Delårsrapport Q2'25

27.11
2025

Delårsrapport Q3'25

Alle
Analyse
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Pressemeddelelsei går

Redeye: FluoGuide Q1 2025 - Phase II HNC readout around the corner

FluoGuide
Selskabsmeddelelsei går

FluoGuide A/S publishes interim report for the period January – March 2025 - On track - first patients enrolled in CT-005

FluoGuide
Pressemeddelelse15.4.2025, 08.28

FluoGuide includes first patient in phase II trial of FG001 for head and neck cancer

FluoGuide

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Selskabsmeddelelse27.3.2025, 14.50

Minutes from Annual General Meeting in FluoGuide A/S

FluoGuide
Selskabsmeddelelse12.3.2025, 08.49

Notice of Annual General Meeting in FluoGuide A/S

FluoGuide
Pressemeddelelse28.2.2025, 07.31

Redeye: FluoGuide Q4 2024 - Edging closer to clinical results

FluoGuide
Selskabsmeddelelse27.2.2025, 06.03

FluoGuide A/S publishes year-end and annual report for the fiscal year 2024

FluoGuide
Selskabsmeddelelse27.2.2025, 06.00

FluoGuide A/S publishes interim report for the period January – December 2024

FluoGuide
Dagens aktienyheder 29/01: Føroya Banki, FluoGuide A/S, Curasight og Ascelia Pharma AB
Analytikerkommentar29.1.2025, 07.59

Dagens aktienyheder 29/01: Føroya Banki, FluoGuide A/S, Curasight og Ascelia Pharma AB

Dagens aktienyheder med Føroya Banki, FluoGuide A/S, Curasight og Ascelia Pharma AB

Føroya BankiFluoGuideCurasightAscelia Pharma
Pressemeddelelse15.1.2025, 15.34

FluoGuide A/S receives approval for phase II trial in head and neck cancer

FluoGuide
Pressemeddelelse27.11.2024, 15.05

Redeye: Fluoguide Q3 2024 - Gearing up for high-impact catalysts in 2025e

FluoGuide
Selskabsmeddelelse27.11.2024, 06.00

FluoGuide A/S publishes interim report for the period January – September 2024

FluoGuide
Pressemeddelelse19.11.2024, 12.43

Publication of positive phase II clinical data for FG001 in patients with head and neck cancer

FluoGuide
Selskabsmeddelelse12.11.2024, 17.23

FluoGuide A/S issue warrants to board member, CMO and CFO

FluoGuide
Pressemeddelelse21.10.2024, 14.13

Roger Gunnarsson resigns as board member due to return to a full-time investment banking career, which precludes him from holding board position in FluoGuide

FluoGuide
Pressemeddelelse7.10.2024, 11.13

FluoGuide A/S submits Clinical Trial Application for phase II trial in head and neck cancer

FluoGuide
Pressemeddelelse29.8.2024, 17.19

Redeye: Fluoguide Q2 2024 - Following the plan

FluoGuide
Selskabsmeddelelse29.8.2024, 06.55

FluoGuide A/S publishes interim report for the period January – June 2024

FluoGuide
Selskabsmeddelelse26.8.2024, 07.05

FluoGuide appoints Jens Ellrich as Chief Medical Officer

FluoGuide
Selskabsmeddelelse18.6.2024, 21.12

FluoGuide has completed a directed share issue to existing and new investors raising proceeds of SEK 60 million

FluoGuide
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team